Literature DB >> 3312662

Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women.

S Landesman1, H Minkoff, S Holman, S McCalla, O Sijin.   

Abstract

Although perinatal transmission of the human immunodeficiency virus (HIV) is well documented, seroprevalence rates of HIV in populations of women of reproductive age have not yet been reported. To determine the seroprevalence of HIV in childbearing women from a population with a high incidence of acquired immunodeficiency syndrome, cord blood samples were collected from 602 infants delivered at an inner-city municipal hospital in New York. Demographic and HIV risk factor information was also collected from mothers of these infants. Twelve (2%) of 602 samples (95% confidence interval, 1% to 4%) were positive for HIV on enzyme-linked immunosorbent assay and Western blot analysis. In interviews, seven of 12 seropositive women had risk factors as defined by the Centers for Disease Control, Atlanta; the remaining five seropositive women had no self-identified risk factors. The HIV seroprevalence rate in our hospital (2.0%) is several times higher than that of many other diseases for which screening is already routine. This serosurvey indicates that HIV infection of inner-city parturients is a significant problem that warrants broadly implemented health strategies. Furthermore, the data also suggest that if risk factor information elicited by physicians is used to initiate HIV antibody counseling and testing of pregnant women, a significant number of seropositive parturients is missed. In areas with significant seroprevalence rates of HIV infection, a broader counseling and testing program may be needed.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health; New York City

Mesh:

Year:  1987        PMID: 3312662

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

1.  Screening for HIV during pregnancy. Survey of physicians' practices.

Authors:  S E MacDonald; L A Hartling; R M Seguin; K S O'Connor; M L Rekart; D L Mowat; J R Hoey
Journal:  Can Fam Physician       Date:  2001-11       Impact factor: 3.275

2.  Periodic health examination, 1992 update: 3. HIV antibody screening. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-09-15       Impact factor: 8.262

3.  HIV and surgeons.

Authors:  B G Gazzard; C Wastell
Journal:  BMJ       Date:  1990-11-03

4.  Newborn seroprevalence study: methods and results.

Authors:  L F Novick; D M Glebatis; R L Stricof; P A MacCubbin; L Lessner; D S Berns
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

5.  Antenatal testing for HIV.

Authors:  J Catalan; J Meadows; Y Stone; S Barton; N Hulme
Journal:  BMJ       Date:  1991-06-08

Review 6.  The ethics of screening for early intervention in HIV disease.

Authors:  C Levine; R Bayer
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

Review 7.  Monitoring the prevalence of HIV.

Authors:  O N Gill; M W Adler; N E Day
Journal:  BMJ       Date:  1989-11-25

8.  Prenatal HIV testing in Ontario: knowledge, attitudes and practices of prenatal care providers in a province with low testing rates.

Authors:  Dale Guenter; June Carroll; Janusz Kaczorowski; John Sellors
Journal:  Can J Public Health       Date:  2003 Mar-Apr

9.  Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada.

Authors:  L Samson; S King
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

10.  Immunoglobulins and growth parameters at birth of infants born to HIV seropositive and seronegative women.

Authors:  A Butz; N Hutton; E Larson
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.